Navigation Links
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
Date:2/28/2013

://www.adventrx.com/">www.adventrx.com.  

Forward Looking Statements
ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that are based on ADVENTRX's current expectations and assumptions. Such forward-looking statements include, but are not limited to, statements regarding ADVENTRX's development plans for ANX-188 in acute limb ischemia and other complications of arterial disease and the timing of activities related to those plans.  Among the factors that could cause or contribute to material differences between ADVENTRX's actual results and expectations indicated by the forward-looking statements are risks and uncertainties that include, but are not limited to: the potential for delays in the commencement or completion of clinical studies, including as a result of difficulties in obtaining regulatory agency agreement on clinical development plans or clinical study design, opening trial sites, enrolling study subjects, manufacturing clinical trial material, completing manufacturing process development activities, and being subject to a "clinical hold"; the risk of suspension or termination of a clinical study, including due to lack of adequate funding or patient safety concerns; the potential for institutional review boards or the FDA or other regulatory agencies to require additional nonclinical or clinical studies prior to initiation of planned phase 2 clinical studies of ANX-188 in any particular indication in which ADVENTRX determines to develop ANX-188, including ALI, which likely would increase the total time and cost of development in the indication; the risk that clinical studies of ANX-188 are not successfully executed and/or do not successfully demonstrate its safety or efficacy; the risk that, even if clinical studies are successful, the FDA determines they are not sufficient to support a new drug application; the risk that even if clinic
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Pharmaceuticals To Present At 2012 BIO International Convention Business Forum
2. ADVENTRX Announces Manufacturing Agreement With Patheon to Manufacture ANX-188 Drug Product
3. ADVENTRX Pharmaceuticals To Present At The OneMedForum New York 2012 Emerging Company Finance Conference On July 12
4. ADVENTRX Applauds Inclusion of Rare Diseases Provisions in the FDA Safety and Innovation Act
5. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
6. ADVENTRX Announces Appointment Of Chief Medical Officer
7. ADVENTRX Pharmaceuticals To Present At The Rodman & Renshaw Annual Global Investment Conference On September 10
8. ADVENTRX Announces Appointment Of Ted W. Love M.D. To Board Of Directors
9. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
10. ADVENTRX Reports Third Quarter 2012 Financial Results
11. ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 WuXi PharmaTech (Cayman) Inc. ... and technology platform company serving the pharmaceutical, biotechnology and ... and the United States ... for the second-quarter of 2015 after the New York ... will be Friday morning, August 14, 2015 Shanghai time). ...
(Date:7/29/2015)... SAN DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... ended June 30, 2015. For the second quarter of 2015, the ... per share, compared to a net loss of $13.4 million, or ... the six months ended June 30, 2015, the Company reported a ... compared to net loss of $25.2 million, or $0.35 loss per ...
(Date:7/29/2015)... July 29, 2015 Sangamo BioSciences, Inc. (NASDAQ: ... release its second quarter 2015 financial results after the ... release will be followed by a conference call at ... public via telephone and webcast. During the conference call, ... discuss other business matters. The conference call ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast 2
... Nov. 1, 2011 Cambrex Corporation (NYSE: ... will be released on Thursday, November 3, 2011 after ... host a conference call to discuss the third quarter ... Friday, November 4, 2011 at 8:30 a.m. Eastern Time ...
... Inc. (NASDAQ: HSIC ), the largest provider ... reported record financial results for the quarter ended September ... and related profits were lower this quarter than in ... meaningful commentary the Company will be discussing results including ...
Cached Medicine Technology:Henry Schein Reports Record Third Quarter Results 2Henry Schein Reports Record Third Quarter Results 3Henry Schein Reports Record Third Quarter Results 4Henry Schein Reports Record Third Quarter Results 5Henry Schein Reports Record Third Quarter Results 6Henry Schein Reports Record Third Quarter Results 7Henry Schein Reports Record Third Quarter Results 8Henry Schein Reports Record Third Quarter Results 9Henry Schein Reports Record Third Quarter Results 10Henry Schein Reports Record Third Quarter Results 11
(Date:7/30/2015)... ... ... Summer is the dry eye season, especially in parts of the country ... hot 2015 summer season and the dry eye rate in the hot spots and ... 2015 summer season and identify the primary dry eye hot spots on her upcoming ...
(Date:7/30/2015)... ... 30, 2015 , ... HEALTHCAREfirst , the leading provider of cloud-based software, ... is hosting a free webinar detailing the 2016 proposed rule from CMS for home ... Vice President of Regulatory Affairs for the National Association for Home Care and Hospice ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... At the presentation of the 2015 Annual ... was focused on research presented by the Journal of Arthroplasty pertaining to how ... like driving. , Results of the study confirm what Santa Rosa Orthopaedics (SRO) ...
(Date:7/30/2015)... ... July 30, 2015 , ... Diagnotes, ... and reporting for reimbursement from the Centers for Medicare & Medicaid Services (CMS) ... providers are experimenting with manual data capture or, in many cases, just deciding ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Addictions Training ... courses for people to become Certified Alcohol and Substance Abuse Counselors. , "We are ... . “There is an acute shortage of Alcohol and Drug Counselors nationwide. ...
Breaking Medicine News(10 mins):Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 2Health News:Diagnotes Announces Expansion of its Mobile Healthcare Communication System to Include Chronic Care Management Reimbursement Support 3Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2
... bacteria, scientists had been able to use light as ... cavity. ,The dental samples obtained from patients suffering ... to 520nm). The light had selectively killed oral black-pigmented ... samples obtained from patients. Medium strength light had killed ...
... team from the University of Western Ontario had found out that ... ,The study used a robot arm to show how ... the video of this learning process was shown to a group, ... the people in the video. Moreover people who learned the same ...
... scientists, consuming food with high glycemic index have been //linked ... which had spanned 16.6 years and observed the incidence of ... is much significant for women who are past their menopause. ... foods that have simple carbohydrates and sugars like refined flour, ...
... can lead to mothers being less emotionally involved with ... a new study done by researchers of Pennsylvania State ... pregnancy and childbirth was previously related to post-partum depression ... The new study suggests that bonding with their newborns ...
... the second phase of testing of the vaccine for ... cancers and 90% of genital warts. ,277 women ... months and regularly had gynecological examination, cervicovaginal sampling for ... to HPV. , ,The results showed the incidence ...
... the pattern of rising early from bed in the mornings ... ,The behavior is called familial advanced sleep phase ... is said to be the phenotype of the gene PER2. ... the phosphorylation site in the casein kinase I (CKI) domain ...
Cached Medicine News:
Pocket-sized instrument with 2.5X magnification....
Durable, simple and easy to use. Lightweight, base can detach and be used as a penlight....
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 3.5V xenon ... of examination area. Used ...
Medicine Products: